Swirsky Douglas J
CIK: 0001375884•CHIEF FINANCIAL OFFICER
OfficerDirector
Primary company: GENVEC INC (GNVC)
Swirsky Douglas J is a corporate insider (CHIEF FINANCIAL OFFICER) at GENVEC INC (GNVC) filing SEC Form 4 transactions. 75 transactions across 8 companies, totaling $236,328 in purchases and $22,061 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 37,500 | $2.70 | $101K | 37,500 | 7/7/2026 Filed: 7/7/2026 | Filing → | |
MAXCYTE, INC. MXCT | Purchase | 50,000 | $1.29 | $65K | 161,811 | 8/13/2025 Filed: 8/13/2025 | Filing → |
MAXCYTE, INC. MXCT | Sale | 6,939 | $3.18 | $22K | 111,811 | 3/18/2025 Filed: 3/20/2025 | Filing → |
MAXCYTE, INC. MXCT | Award | 150,000 | $3.29 | $494K | 150,000 | 3/14/2025 Filed: 3/18/2025 | Filing → |
MAXCYTE, INC. MXCT | Award | 37,500 | - | - | 118,750 | 3/14/2025 Filed: 3/18/2025 | Filing → |
| Award | 90,000 | $0.29 | $26K | 90,000 | 2/14/2025 Filed: 2/18/2025 | Filing → | |
| Award | 90,000 | - | - | 90,000 | 6/14/2024 Filed: 6/18/2024 | Filing → | |
MAXCYTE, INC. MXCT | Award | 225,000 | - | - | 225,000 | 3/15/2024 Filed: 3/19/2024 | Filing → |
MAXCYTE, INC. MXCT | Award | 81,250 | - | - | 81,250 | 3/15/2024 Filed: 3/19/2024 | Filing → |
| Award | 37,500 | $0.00 | $0 | 71,925 | 6/28/2023 Filed: 6/28/2023 | Filing → | |
MAXCYTE, INC. MXCT | Award | 350,000 | $0.00 | $0 | 350,000 | 3/27/2023 Filed: 3/28/2023 | Filing → |
| Award | 11,700 | $0.00 | $0 | 11,700 | 6/24/2022 Filed: 8/1/2022 | Filing → | |
| Purchase | 25,000 | $1.04 | $26K | 25,000 | 9/14/2021 Filed: 9/14/2021 | Filing → | |
| Award | 117,000 | $0.00 | $0 | 117,000 | 6/30/2021 Filed: 7/2/2021 | Filing → | |
NeuroBo Pharmaceuticals, Inc. NRBO | Award | 60,000 | $0.00 | $0 | 60,000 | 9/1/2020 Filed: 9/3/2020 | Filing → |
| Award | 80,000 | $0.00 | $0 | 80,000 | 6/24/2020 Filed: 6/25/2020 | Filing → | |
| Award | 9,750 | $0.00 | $0 | 9,750 | 6/13/2019 Filed: 6/14/2019 | Filing → | |
Fibrocell Science, Inc. FCSC | Award | 12,000 | - | - | 12,000 | 6/12/2019 Filed: 6/14/2019 | Filing → |
REXAHN PHARMACEUTICALS, INC. RNN | Purchase | 50,000 | $0.63 | $32K | 50,000 | 1/29/2019 Filed: 1/30/2019 | Filing → |
REXAHN PHARMACEUTICALS, INC. RNN | Award | 500,000 | $0.00 | $0 | 500,000 | 11/14/2018 Filed: 11/16/2018 | Filing → |
Type
Award
Shares
37,500
Price
$2.70
Value
$101K
MAXCYTE, INC.
MXCT
Type
Purchase
Shares
50,000
Price
$1.29
Value
$65K
MAXCYTE, INC.
MXCT
Type
Sale
Shares
6,939
Price
$3.18
Value
$22K
MAXCYTE, INC.
MXCT
Type
Award
Shares
150,000
Price
$3.29
Value
$494K
MAXCYTE, INC.
MXCT
Type
Award
Shares
37,500
Price
-
Value
-
Type
Award
Shares
90,000
Price
$0.29
Value
$26K
Type
Award
Shares
90,000
Price
-
Value
-
MAXCYTE, INC.
MXCT
Type
Award
Shares
225,000
Price
-
Value
-
MAXCYTE, INC.
MXCT
Type
Award
Shares
81,250
Price
-
Value
-
Type
Award
Shares
37,500
Price
$0.00
Value
$0
MAXCYTE, INC.
MXCT
Type
Award
Shares
350,000
Price
$0.00
Value
$0
Type
Award
Shares
11,700
Price
$0.00
Value
$0
Type
Purchase
Shares
25,000
Price
$1.04
Value
$26K
Type
Award
Shares
117,000
Price
$0.00
Value
$0
NeuroBo Pharmaceuticals, Inc.
NRBO
Type
Award
Shares
60,000
Price
$0.00
Value
$0
Type
Award
Shares
80,000
Price
$0.00
Value
$0
Type
Award
Shares
9,750
Price
$0.00
Value
$0
Fibrocell Science, Inc.
FCSC
Type
Award
Shares
12,000
Price
-
Value
-
REXAHN PHARMACEUTICALS, INC.
RNN
Type
Purchase
Shares
50,000
Price
$0.63
Value
$32K
REXAHN PHARMACEUTICALS, INC.
RNN
Type
Award
Shares
500,000
Price
$0.00
Value
$0
AI Agent
Try asking...